nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—SIGMAR1—Progesterone—uterine cancer	0.153	0.228	CbGbCtD
Amitriptyline—OPRK1—Progesterone—uterine cancer	0.109	0.163	CbGbCtD
Amitriptyline—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0472	0.0704	CbGbCtD
Amitriptyline—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0329	0.0491	CbGbCtD
Amitriptyline—CYP3A5—Progesterone—uterine cancer	0.0325	0.0485	CbGbCtD
Amitriptyline—CYP2C8—Progesterone—uterine cancer	0.0313	0.0467	CbGbCtD
Amitriptyline—CYP2C19—Progesterone—uterine cancer	0.0262	0.0392	CbGbCtD
Amitriptyline—CYP1A2—Progesterone—uterine cancer	0.0242	0.0361	CbGbCtD
Amitriptyline—CYP2C9—Progesterone—uterine cancer	0.0218	0.0325	CbGbCtD
Amitriptyline—ABCB1—Progesterone—uterine cancer	0.0212	0.0316	CbGbCtD
Amitriptyline—CYP2D6—Progesterone—uterine cancer	0.0199	0.0298	CbGbCtD
Amitriptyline—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0191	0.0286	CbGbCtD
Amitriptyline—CYP2E1—Etoposide—uterine cancer	0.0187	0.028	CbGbCtD
Amitriptyline—ABCB1—Dactinomycin—uterine cancer	0.0168	0.025	CbGbCtD
Amitriptyline—CYP3A5—Etoposide—uterine cancer	0.0145	0.0217	CbGbCtD
Amitriptyline—CYP2C8—Etoposide—uterine cancer	0.014	0.0209	CbGbCtD
Amitriptyline—CYP3A4—Progesterone—uterine cancer	0.0127	0.0189	CbGbCtD
Amitriptyline—CYP2B6—Doxorubicin—uterine cancer	0.0126	0.0188	CbGbCtD
Amitriptyline—CYP1A2—Etoposide—uterine cancer	0.0108	0.0162	CbGbCtD
Amitriptyline—ABCB1—Etoposide—uterine cancer	0.00947	0.0141	CbGbCtD
Amitriptyline—CHRM3—ureter—uterine cancer	0.00779	0.0862	CbGeAlD
Amitriptyline—ABCB1—Doxorubicin—uterine cancer	0.00646	0.00964	CbGbCtD
Amitriptyline—CYP2D6—Doxorubicin—uterine cancer	0.00609	0.00908	CbGbCtD
Amitriptyline—CYP3A4—Etoposide—uterine cancer	0.00567	0.00847	CbGbCtD
Amitriptyline—CHRM3—muscle of abdomen—uterine cancer	0.00561	0.062	CbGeAlD
Amitriptyline—CYP3A4—Doxorubicin—uterine cancer	0.00387	0.00578	CbGbCtD
Amitriptyline—NTRK1—decidua—uterine cancer	0.00344	0.038	CbGeAlD
Amitriptyline—KCND2—myometrium—uterine cancer	0.00235	0.0259	CbGeAlD
Amitriptyline—HTR1B—artery—uterine cancer	0.00217	0.024	CbGeAlD
Amitriptyline—HTR1D—artery—uterine cancer	0.00211	0.0233	CbGeAlD
Amitriptyline—SIGMAR1—Levonorgestrel—Progesterone—uterine cancer	0.00209	1	CbGdCrCtD
Amitriptyline—NTRK2—female reproductive system—uterine cancer	0.00207	0.0229	CbGeAlD
Amitriptyline—NTRK2—female gonad—uterine cancer	0.00188	0.0208	CbGeAlD
Amitriptyline—KCND2—decidua—uterine cancer	0.00174	0.0192	CbGeAlD
Amitriptyline—HTR7—artery—uterine cancer	0.00168	0.0185	CbGeAlD
Amitriptyline—KCND3—uterine cervix—uterine cancer	0.00159	0.0176	CbGeAlD
Amitriptyline—KCNQ3—female reproductive system—uterine cancer	0.00157	0.0173	CbGeAlD
Amitriptyline—CHRM3—exocrine gland—uterine cancer	0.00154	0.017	CbGeAlD
Amitriptyline—KCNQ2—female reproductive system—uterine cancer	0.00144	0.016	CbGeAlD
Amitriptyline—KCND3—uterus—uterine cancer	0.00133	0.0147	CbGeAlD
Amitriptyline—KCNQ2—female gonad—uterine cancer	0.00131	0.0145	CbGeAlD
Amitriptyline—KCND2—female gonad—uterine cancer	0.00124	0.0138	CbGeAlD
Amitriptyline—OPRD1—renal system—uterine cancer	0.00123	0.0135	CbGeAlD
Amitriptyline—NTRK2—lymph node—uterine cancer	0.00121	0.0134	CbGeAlD
Amitriptyline—CHRM5—epithelium—uterine cancer	0.00119	0.0132	CbGeAlD
Amitriptyline—ADRA1D—epithelium—uterine cancer	0.00107	0.0118	CbGeAlD
Amitriptyline—HTR2A—artery—uterine cancer	0.00105	0.0116	CbGeAlD
Amitriptyline—ADRA1B—renal system—uterine cancer	0.00101	0.0112	CbGeAlD
Amitriptyline—SIGMAR1—myometrium—uterine cancer	0.000948	0.0105	CbGeAlD
Amitriptyline—OPRK1—female reproductive system—uterine cancer	0.000941	0.0104	CbGeAlD
Amitriptyline—ADRA1D—female reproductive system—uterine cancer	0.000793	0.00877	CbGeAlD
Amitriptyline—ORM1—endometrium—uterine cancer	0.000789	0.00872	CbGeAlD
Amitriptyline—SIGMAR1—uterine cervix—uterine cancer	0.000738	0.00816	CbGeAlD
Amitriptyline—SIGMAR1—smooth muscle tissue—uterine cancer	0.000717	0.00793	CbGeAlD
Amitriptyline—SIGMAR1—decidua—uterine cancer	0.000703	0.00777	CbGeAlD
Amitriptyline—KCND3—lymph node—uterine cancer	0.000697	0.00771	CbGeAlD
Amitriptyline—SIGMAR1—endometrium—uterine cancer	0.000667	0.00738	CbGeAlD
Amitriptyline—ORM1—female reproductive system—uterine cancer	0.000653	0.00722	CbGeAlD
Amitriptyline—SIGMAR1—mammalian vulva—uterine cancer	0.000646	0.00714	CbGeAlD
Amitriptyline—CHRM3—smooth muscle tissue—uterine cancer	0.000644	0.00712	CbGeAlD
Amitriptyline—HTR7—epithelium—uterine cancer	0.000636	0.00703	CbGeAlD
Amitriptyline—SLC6A2—decidua—uterine cancer	0.000623	0.00689	CbGeAlD
Amitriptyline—CHRM3—renal system—uterine cancer	0.00062	0.00685	CbGeAlD
Amitriptyline—HTR1A—renal system—uterine cancer	0.000617	0.00682	CbGeAlD
Amitriptyline—SIGMAR1—uterus—uterine cancer	0.000615	0.0068	CbGeAlD
Amitriptyline—ADRA1A—epithelium—uterine cancer	0.000613	0.00678	CbGeAlD
Amitriptyline—HTR7—smooth muscle tissue—uterine cancer	0.000613	0.00677	CbGeAlD
Amitriptyline—HTR1B—female reproductive system—uterine cancer	0.000612	0.00677	CbGeAlD
Amitriptyline—HRH1—myometrium—uterine cancer	0.000605	0.00669	CbGeAlD
Amitriptyline—ADRA2A—myometrium—uterine cancer	0.000594	0.00657	CbGeAlD
Amitriptyline—HTR1D—female reproductive system—uterine cancer	0.000593	0.00656	CbGeAlD
Amitriptyline—HTR7—renal system—uterine cancer	0.00059	0.00652	CbGeAlD
Amitriptyline—HTR2C—female reproductive system—uterine cancer	0.000587	0.00649	CbGeAlD
Amitriptyline—ADRA1A—renal system—uterine cancer	0.000569	0.00629	CbGeAlD
Amitriptyline—SLC6A4—female reproductive system—uterine cancer	0.000557	0.00615	CbGeAlD
Amitriptyline—CHRM1—female reproductive system—uterine cancer	0.000555	0.00613	CbGeAlD
Amitriptyline—HRH2—lymph node—uterine cancer	0.000544	0.00601	CbGeAlD
Amitriptyline—Hyperhidrosis—Progesterone—uterine cancer	0.000509	0.00343	CcSEcCtD
Amitriptyline—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.000507	0.00341	CcSEcCtD
Amitriptyline—SIGMAR1—female gonad—uterine cancer	0.000503	0.00556	CbGeAlD
Amitriptyline—CYP2C8—renal system—uterine cancer	0.000503	0.00556	CbGeAlD
Amitriptyline—Anorexia—Progesterone—uterine cancer	0.000502	0.00338	CcSEcCtD
Amitriptyline—SIGMAR1—vagina—uterine cancer	0.0005	0.00553	CbGeAlD
Amitriptyline—CHRM3—female reproductive system—uterine cancer	0.000496	0.00549	CbGeAlD
Amitriptyline—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.000496	0.00334	CcSEcCtD
Amitriptyline—Hypotension—Progesterone—uterine cancer	0.000492	0.00331	CcSEcCtD
Amitriptyline—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000492	0.00331	CcSEcCtD
Amitriptyline—SLC6A2—female reproductive system—uterine cancer	0.00049	0.00542	CbGeAlD
Amitriptyline—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.000487	0.00328	CcSEcCtD
Amitriptyline—CYP2C8—endometrium—uterine cancer	0.000486	0.00537	CbGeAlD
Amitriptyline—CYP3A5—uterine cervix—uterine cancer	0.000485	0.00536	CbGeAlD
Amitriptyline—Ageusia—Doxorubicin—uterine cancer	0.000484	0.00325	CcSEcCtD
Amitriptyline—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.000481	0.00324	CcSEcCtD
Amitriptyline—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000477	0.00321	CcSEcCtD
Amitriptyline—Insomnia—Progesterone—uterine cancer	0.000476	0.00321	CcSEcCtD
Amitriptyline—HRH1—epithelium—uterine cancer	0.000475	0.00525	CbGeAlD
Amitriptyline—Paraesthesia—Progesterone—uterine cancer	0.000473	0.00318	CcSEcCtD
Amitriptyline—HTR7—female reproductive system—uterine cancer	0.000472	0.00522	CbGeAlD
Amitriptyline—HRH1—uterine cervix—uterine cancer	0.000471	0.0052	CbGeAlD
Amitriptyline—CYP1A2—renal system—uterine cancer	0.00047	0.0052	CbGeAlD
Amitriptyline—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00047	0.00316	CcSEcCtD
Amitriptyline—Somnolence—Progesterone—uterine cancer	0.000468	0.00315	CcSEcCtD
Amitriptyline—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000467	0.00314	CcSEcCtD
Amitriptyline—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000466	0.00313	CcSEcCtD
Amitriptyline—Dyspepsia—Progesterone—uterine cancer	0.000464	0.00312	CcSEcCtD
Amitriptyline—Alopecia—Dactinomycin—uterine cancer	0.000463	0.00312	CcSEcCtD
Amitriptyline—ADRA2A—uterine cervix—uterine cancer	0.000462	0.00511	CbGeAlD
Amitriptyline—Sweating increased—Etoposide—uterine cancer	0.000462	0.00311	CcSEcCtD
Amitriptyline—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000461	0.0031	CcSEcCtD
Amitriptyline—Decreased appetite—Progesterone—uterine cancer	0.000458	0.00308	CcSEcCtD
Amitriptyline—HRH1—smooth muscle tissue—uterine cancer	0.000457	0.00506	CbGeAlD
Amitriptyline—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000455	0.00306	CcSEcCtD
Amitriptyline—Fatigue—Progesterone—uterine cancer	0.000454	0.00306	CcSEcCtD
Amitriptyline—CYP3A5—renal system—uterine cancer	0.000454	0.00502	CbGeAlD
Amitriptyline—CHRM3—female gonad—uterine cancer	0.000452	0.00499	CbGeAlD
Amitriptyline—CYP2B6—renal system—uterine cancer	0.000451	0.00499	CbGeAlD
Amitriptyline—Dyskinesia—Epirubicin—uterine cancer	0.000451	0.00303	CcSEcCtD
Amitriptyline—Constipation—Progesterone—uterine cancer	0.00045	0.00303	CcSEcCtD
Amitriptyline—Pancytopenia—Etoposide—uterine cancer	0.00045	0.00303	CcSEcCtD
Amitriptyline—HRH1—decidua—uterine cancer	0.000448	0.00496	CbGeAlD
Amitriptyline—Dysarthria—Epirubicin—uterine cancer	0.000448	0.00301	CcSEcCtD
Amitriptyline—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000446	0.003	CcSEcCtD
Amitriptyline—ADRA2A—decidua—uterine cancer	0.000441	0.00487	CbGeAlD
Amitriptyline—Atrioventricular block—Epirubicin—uterine cancer	0.000436	0.00294	CcSEcCtD
Amitriptyline—Feeling abnormal—Progesterone—uterine cancer	0.000434	0.00292	CcSEcCtD
Amitriptyline—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000432	0.0029	CcSEcCtD
Amitriptyline—Coordination abnormal—Epirubicin—uterine cancer	0.000431	0.0029	CcSEcCtD
Amitriptyline—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000429	0.00288	CcSEcCtD
Amitriptyline—HRH1—endometrium—uterine cancer	0.000426	0.00471	CbGeAlD
Amitriptyline—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000424	0.00286	CcSEcCtD
Amitriptyline—Ventricular tachycardia—Epirubicin—uterine cancer	0.000423	0.00285	CcSEcCtD
Amitriptyline—Ill-defined disorder—Dactinomycin—uterine cancer	0.000423	0.00285	CcSEcCtD
Amitriptyline—CYP2E1—renal system—uterine cancer	0.000423	0.00468	CbGeAlD
Amitriptyline—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00042	0.00283	CcSEcCtD
Amitriptyline—Urticaria—Progesterone—uterine cancer	0.000418	0.00282	CcSEcCtD
Amitriptyline—ADRA2A—endometrium—uterine cancer	0.000418	0.00462	CbGeAlD
Amitriptyline—CYP2C19—vagina—uterine cancer	0.000417	0.00461	CbGeAlD
Amitriptyline—Dyskinesia—Doxorubicin—uterine cancer	0.000417	0.0028	CcSEcCtD
Amitriptyline—Acute coronary syndrome—Etoposide—uterine cancer	0.000417	0.0028	CcSEcCtD
Amitriptyline—Body temperature increased—Progesterone—uterine cancer	0.000416	0.0028	CcSEcCtD
Amitriptyline—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000415	0.00279	CcSEcCtD
Amitriptyline—Dysarthria—Doxorubicin—uterine cancer	0.000414	0.00279	CcSEcCtD
Amitriptyline—Myocardial infarction—Etoposide—uterine cancer	0.000414	0.00279	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Etoposide—uterine cancer	0.000414	0.00279	CcSEcCtD
Amitriptyline—Jaundice—Etoposide—uterine cancer	0.000412	0.00277	CcSEcCtD
Amitriptyline—Stomatitis—Etoposide—uterine cancer	0.000412	0.00277	CcSEcCtD
Amitriptyline—HRH1—mammalian vulva—uterine cancer	0.000412	0.00455	CbGeAlD
Amitriptyline—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000412	0.00277	CcSEcCtD
Amitriptyline—Malaise—Dactinomycin—uterine cancer	0.000411	0.00277	CcSEcCtD
Amitriptyline—Leukopenia—Dactinomycin—uterine cancer	0.000408	0.00275	CcSEcCtD
Amitriptyline—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000408	0.00275	CcSEcCtD
Amitriptyline—ADRA2A—mammalian vulva—uterine cancer	0.000405	0.00447	CbGeAlD
Amitriptyline—Atrioventricular block—Doxorubicin—uterine cancer	0.000404	0.00272	CcSEcCtD
Amitriptyline—CYP2C8—female reproductive system—uterine cancer	0.000403	0.00445	CbGeAlD
Amitriptyline—Coordination abnormal—Doxorubicin—uterine cancer	0.000399	0.00268	CcSEcCtD
Amitriptyline—HTR2A—epithelium—uterine cancer	0.000397	0.00438	CbGeAlD
Amitriptyline—Agranulocytosis—Etoposide—uterine cancer	0.000394	0.00265	CcSEcCtD
Amitriptyline—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000393	0.00265	CcSEcCtD
Amitriptyline—Ventricular tachycardia—Doxorubicin—uterine cancer	0.000392	0.00264	CcSEcCtD
Amitriptyline—Coma—Epirubicin—uterine cancer	0.000387	0.0026	CcSEcCtD
Amitriptyline—ADRA2A—uterus—uterine cancer	0.000385	0.00426	CbGeAlD
Amitriptyline—Discomfort—Dactinomycin—uterine cancer	0.000384	0.00258	CcSEcCtD
Amitriptyline—ORM1—lymph node—uterine cancer	0.000382	0.00423	CbGeAlD
Amitriptyline—HTR2A—smooth muscle tissue—uterine cancer	0.000382	0.00422	CbGeAlD
Amitriptyline—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000379	0.00255	CcSEcCtD
Amitriptyline—Asthenia—Progesterone—uterine cancer	0.000378	0.00254	CcSEcCtD
Amitriptyline—Hypoaesthesia—Etoposide—uterine cancer	0.000377	0.00254	CcSEcCtD
Amitriptyline—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000377	0.00254	CcSEcCtD
Amitriptyline—Pruritus—Progesterone—uterine cancer	0.000373	0.00251	CcSEcCtD
Amitriptyline—Oedema—Dactinomycin—uterine cancer	0.000372	0.00251	CcSEcCtD
Amitriptyline—HTR2A—renal system—uterine cancer	0.000368	0.00407	CbGeAlD
Amitriptyline—Mental disability—Epirubicin—uterine cancer	0.000367	0.00247	CcSEcCtD
Amitriptyline—Thrombocytopenia—Dactinomycin—uterine cancer	0.000365	0.00245	CcSEcCtD
Amitriptyline—CYP2C8—vagina—uterine cancer	0.000364	0.00403	CbGeAlD
Amitriptyline—CYP2B6—female reproductive system—uterine cancer	0.000361	0.00399	CbGeAlD
Amitriptyline—Diarrhoea—Progesterone—uterine cancer	0.00036	0.00243	CcSEcCtD
Amitriptyline—Coma—Doxorubicin—uterine cancer	0.000358	0.00241	CcSEcCtD
Amitriptyline—CYP2C9—female reproductive system—uterine cancer	0.000358	0.00395	CbGeAlD
Amitriptyline—Anorexia—Dactinomycin—uterine cancer	0.000355	0.00239	CcSEcCtD
Amitriptyline—HRH1—female reproductive system—uterine cancer	0.000353	0.0039	CbGeAlD
Amitriptyline—Dizziness—Progesterone—uterine cancer	0.000348	0.00234	CcSEcCtD
Amitriptyline—ADRA2A—female reproductive system—uterine cancer	0.000346	0.00383	CbGeAlD
Amitriptyline—Vascular purpura—Epirubicin—uterine cancer	0.000344	0.00231	CcSEcCtD
Amitriptyline—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000342	0.0023	CcSEcCtD
Amitriptyline—Hepatic failure—Epirubicin—uterine cancer	0.000342	0.0023	CcSEcCtD
Amitriptyline—CYP3A4—renal system—uterine cancer	0.000341	0.00376	CbGeAlD
Amitriptyline—Mental disability—Doxorubicin—uterine cancer	0.00034	0.00229	CcSEcCtD
Amitriptyline—CYP2E1—female reproductive system—uterine cancer	0.000339	0.00375	CbGeAlD
Amitriptyline—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000338	0.00227	CcSEcCtD
Amitriptyline—Alopecia—Etoposide—uterine cancer	0.000335	0.00226	CcSEcCtD
Amitriptyline—ALB—lymph node—uterine cancer	0.000335	0.0037	CbGeAlD
Amitriptyline—CYP2D6—renal system—uterine cancer	0.000335	0.0037	CbGeAlD
Amitriptyline—Vomiting—Progesterone—uterine cancer	0.000335	0.00225	CcSEcCtD
Amitriptyline—Rash—Progesterone—uterine cancer	0.000332	0.00223	CcSEcCtD
Amitriptyline—Dermatitis—Progesterone—uterine cancer	0.000332	0.00223	CcSEcCtD
Amitriptyline—ABCB1—myometrium—uterine cancer	0.000331	0.00366	CbGeAlD
Amitriptyline—CYP3A5—female gonad—uterine cancer	0.000331	0.00366	CbGeAlD
Amitriptyline—Headache—Progesterone—uterine cancer	0.00033	0.00222	CcSEcCtD
Amitriptyline—CYP3A5—vagina—uterine cancer	0.000329	0.00363	CbGeAlD
Amitriptyline—CYP2B6—vagina—uterine cancer	0.000327	0.00361	CbGeAlD
Amitriptyline—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000327	0.0022	CcSEcCtD
Amitriptyline—Decreased appetite—Dactinomycin—uterine cancer	0.000324	0.00218	CcSEcCtD
Amitriptyline—SIGMAR1—lymph node—uterine cancer	0.000323	0.00358	CbGeAlD
Amitriptyline—Dysgeusia—Etoposide—uterine cancer	0.000323	0.00218	CcSEcCtD
Amitriptyline—Fatigue—Dactinomycin—uterine cancer	0.000321	0.00216	CcSEcCtD
Amitriptyline—HRH1—female gonad—uterine cancer	0.000321	0.00355	CbGeAlD
Amitriptyline—HRH1—vagina—uterine cancer	0.000319	0.00353	CbGeAlD
Amitriptyline—Purpura—Epirubicin—uterine cancer	0.000319	0.00215	CcSEcCtD
Amitriptyline—Vascular purpura—Doxorubicin—uterine cancer	0.000318	0.00214	CcSEcCtD
Amitriptyline—Hepatic failure—Doxorubicin—uterine cancer	0.000316	0.00213	CcSEcCtD
Amitriptyline—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000316	0.00212	CcSEcCtD
Amitriptyline—ADRA2A—female gonad—uterine cancer	0.000315	0.00348	CbGeAlD
Amitriptyline—Cerebrovascular accident—Epirubicin—uterine cancer	0.000314	0.00211	CcSEcCtD
Amitriptyline—ADRA2A—vagina—uterine cancer	0.000313	0.00346	CbGeAlD
Amitriptyline—Nausea—Progesterone—uterine cancer	0.000313	0.00211	CcSEcCtD
Amitriptyline—Osteoarthritis—Epirubicin—uterine cancer	0.000307	0.00207	CcSEcCtD
Amitriptyline—Feeling abnormal—Dactinomycin—uterine cancer	0.000307	0.00206	CcSEcCtD
Amitriptyline—Ill-defined disorder—Etoposide—uterine cancer	0.000306	0.00206	CcSEcCtD
Amitriptyline—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000304	0.00204	CcSEcCtD
Amitriptyline—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000301	0.00203	CcSEcCtD
Amitriptyline—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000301	0.00202	CcSEcCtD
Amitriptyline—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000299	0.00201	CcSEcCtD
Amitriptyline—Malaise—Etoposide—uterine cancer	0.000298	0.002	CcSEcCtD
Amitriptyline—Leukopenia—Etoposide—uterine cancer	0.000296	0.00199	CcSEcCtD
Amitriptyline—Purpura—Doxorubicin—uterine cancer	0.000295	0.00199	CcSEcCtD
Amitriptyline—HTR2A—female reproductive system—uterine cancer	0.000295	0.00326	CbGeAlD
Amitriptyline—Body temperature increased—Dactinomycin—uterine cancer	0.000294	0.00198	CcSEcCtD
Amitriptyline—Loss of consciousness—Etoposide—uterine cancer	0.00029	0.00195	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Doxorubicin—uterine cancer	0.00029	0.00195	CcSEcCtD
Amitriptyline—Ataxia—Epirubicin—uterine cancer	0.000289	0.00194	CcSEcCtD
Amitriptyline—SLC6A2—lymph node—uterine cancer	0.000287	0.00317	CbGeAlD
Amitriptyline—Convulsion—Etoposide—uterine cancer	0.000286	0.00192	CcSEcCtD
Amitriptyline—Hypertension—Etoposide—uterine cancer	0.000285	0.00192	CcSEcCtD
Amitriptyline—Osteoarthritis—Doxorubicin—uterine cancer	0.000284	0.00191	CcSEcCtD
Amitriptyline—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000284	0.00191	CcSEcCtD
Amitriptyline—Orthostatic hypotension—Epirubicin—uterine cancer	0.000281	0.00189	CcSEcCtD
Amitriptyline—Discomfort—Etoposide—uterine cancer	0.000278	0.00187	CcSEcCtD
Amitriptyline—CYP3A4—female reproductive system—uterine cancer	0.000273	0.00301	CbGeAlD
Amitriptyline—Confusional state—Etoposide—uterine cancer	0.000272	0.00183	CcSEcCtD
Amitriptyline—CYP2D6—female reproductive system—uterine cancer	0.000268	0.00297	CbGeAlD
Amitriptyline—Ataxia—Doxorubicin—uterine cancer	0.000267	0.0018	CcSEcCtD
Amitriptyline—Asthenia—Dactinomycin—uterine cancer	0.000267	0.0018	CcSEcCtD
Amitriptyline—HTR2A—vagina—uterine cancer	0.000266	0.00295	CbGeAlD
Amitriptyline—Thrombocytopenia—Etoposide—uterine cancer	0.000264	0.00178	CcSEcCtD
Amitriptyline—Tachycardia—Etoposide—uterine cancer	0.000263	0.00177	CcSEcCtD
Amitriptyline—Eosinophilia—Epirubicin—uterine cancer	0.000263	0.00177	CcSEcCtD
Amitriptyline—Hyperhidrosis—Etoposide—uterine cancer	0.000261	0.00175	CcSEcCtD
Amitriptyline—ABCB1—epithelium—uterine cancer	0.00026	0.00287	CbGeAlD
Amitriptyline—Orthostatic hypotension—Doxorubicin—uterine cancer	0.00026	0.00175	CcSEcCtD
Amitriptyline—ABCB1—uterine cervix—uterine cancer	0.000258	0.00285	CbGeAlD
Amitriptyline—Anorexia—Etoposide—uterine cancer	0.000257	0.00173	CcSEcCtD
Amitriptyline—Diarrhoea—Dactinomycin—uterine cancer	0.000255	0.00171	CcSEcCtD
Amitriptyline—Pancytopenia—Epirubicin—uterine cancer	0.000252	0.0017	CcSEcCtD
Amitriptyline—Hypotension—Etoposide—uterine cancer	0.000252	0.00169	CcSEcCtD
Amitriptyline—ABCB1—decidua—uterine cancer	0.000245	0.00271	CbGeAlD
Amitriptyline—Pollakiuria—Epirubicin—uterine cancer	0.000245	0.00165	CcSEcCtD
Amitriptyline—CYP2D6—female gonad—uterine cancer	0.000244	0.0027	CbGeAlD
Amitriptyline—Eosinophilia—Doxorubicin—uterine cancer	0.000243	0.00164	CcSEcCtD
Amitriptyline—Paraesthesia—Etoposide—uterine cancer	0.000242	0.00163	CcSEcCtD
Amitriptyline—Weight increased—Epirubicin—uterine cancer	0.000242	0.00163	CcSEcCtD
Amitriptyline—ABCB1—renal system—uterine cancer	0.000241	0.00266	CbGeAlD
Amitriptyline—Somnolence—Etoposide—uterine cancer	0.00024	0.00161	CcSEcCtD
Amitriptyline—Drowsiness—Epirubicin—uterine cancer	0.000237	0.00159	CcSEcCtD
Amitriptyline—Vomiting—Dactinomycin—uterine cancer	0.000237	0.00159	CcSEcCtD
Amitriptyline—Rash—Dactinomycin—uterine cancer	0.000235	0.00158	CcSEcCtD
Amitriptyline—Decreased appetite—Etoposide—uterine cancer	0.000234	0.00158	CcSEcCtD
Amitriptyline—Pancytopenia—Doxorubicin—uterine cancer	0.000233	0.00157	CcSEcCtD
Amitriptyline—ABCB1—endometrium—uterine cancer	0.000233	0.00258	CbGeAlD
Amitriptyline—Fatigue—Etoposide—uterine cancer	0.000232	0.00156	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Epirubicin—uterine cancer	0.000232	0.00156	CcSEcCtD
Amitriptyline—Jaundice—Epirubicin—uterine cancer	0.000231	0.00155	CcSEcCtD
Amitriptyline—Stomatitis—Epirubicin—uterine cancer	0.000231	0.00155	CcSEcCtD
Amitriptyline—Constipation—Etoposide—uterine cancer	0.00023	0.00155	CcSEcCtD
Amitriptyline—Pollakiuria—Doxorubicin—uterine cancer	0.000227	0.00153	CcSEcCtD
Amitriptyline—ABCB1—mammalian vulva—uterine cancer	0.000225	0.00249	CbGeAlD
Amitriptyline—Weight increased—Doxorubicin—uterine cancer	0.000224	0.00151	CcSEcCtD
Amitriptyline—Feeling abnormal—Etoposide—uterine cancer	0.000222	0.00149	CcSEcCtD
Amitriptyline—Nausea—Dactinomycin—uterine cancer	0.000221	0.00149	CcSEcCtD
Amitriptyline—Agranulocytosis—Epirubicin—uterine cancer	0.000221	0.00149	CcSEcCtD
Amitriptyline—Drowsiness—Doxorubicin—uterine cancer	0.000219	0.00147	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000215	0.00145	CcSEcCtD
Amitriptyline—ABCB1—uterus—uterine cancer	0.000215	0.00237	CbGeAlD
Amitriptyline—Urticaria—Etoposide—uterine cancer	0.000214	0.00144	CcSEcCtD
Amitriptyline—Jaundice—Doxorubicin—uterine cancer	0.000214	0.00144	CcSEcCtD
Amitriptyline—Stomatitis—Doxorubicin—uterine cancer	0.000214	0.00144	CcSEcCtD
Amitriptyline—Body temperature increased—Etoposide—uterine cancer	0.000213	0.00143	CcSEcCtD
Amitriptyline—Hepatitis—Epirubicin—uterine cancer	0.000213	0.00143	CcSEcCtD
Amitriptyline—Hypoaesthesia—Epirubicin—uterine cancer	0.000212	0.00142	CcSEcCtD
Amitriptyline—HRH1—lymph node—uterine cancer	0.000206	0.00228	CbGeAlD
Amitriptyline—Agranulocytosis—Doxorubicin—uterine cancer	0.000205	0.00138	CcSEcCtD
Amitriptyline—ADRA2A—lymph node—uterine cancer	0.000203	0.00224	CbGeAlD
Amitriptyline—Tinnitus—Epirubicin—uterine cancer	0.000198	0.00133	CcSEcCtD
Amitriptyline—Hepatitis—Doxorubicin—uterine cancer	0.000197	0.00132	CcSEcCtD
Amitriptyline—Hypoaesthesia—Doxorubicin—uterine cancer	0.000196	0.00132	CcSEcCtD
Amitriptyline—Asthenia—Etoposide—uterine cancer	0.000193	0.0013	CcSEcCtD
Amitriptyline—ABCB1—female reproductive system—uterine cancer	0.000193	0.00213	CbGeAlD
Amitriptyline—Pruritus—Etoposide—uterine cancer	0.000191	0.00128	CcSEcCtD
Amitriptyline—Arrhythmia—Epirubicin—uterine cancer	0.00019	0.00128	CcSEcCtD
Amitriptyline—Alopecia—Epirubicin—uterine cancer	0.000188	0.00126	CcSEcCtD
Amitriptyline—Diarrhoea—Etoposide—uterine cancer	0.000184	0.00124	CcSEcCtD
Amitriptyline—Tinnitus—Doxorubicin—uterine cancer	0.000183	0.00123	CcSEcCtD
Amitriptyline—Dysgeusia—Epirubicin—uterine cancer	0.000181	0.00122	CcSEcCtD
Amitriptyline—Dizziness—Etoposide—uterine cancer	0.000178	0.0012	CcSEcCtD
Amitriptyline—Arrhythmia—Doxorubicin—uterine cancer	0.000176	0.00118	CcSEcCtD
Amitriptyline—ABCB1—female gonad—uterine cancer	0.000176	0.00194	CbGeAlD
Amitriptyline—ABCB1—vagina—uterine cancer	0.000175	0.00193	CbGeAlD
Amitriptyline—Vision blurred—Epirubicin—uterine cancer	0.000174	0.00117	CcSEcCtD
Amitriptyline—Alopecia—Doxorubicin—uterine cancer	0.000174	0.00117	CcSEcCtD
Amitriptyline—Ill-defined disorder—Epirubicin—uterine cancer	0.000172	0.00116	CcSEcCtD
Amitriptyline—Vomiting—Etoposide—uterine cancer	0.000171	0.00115	CcSEcCtD
Amitriptyline—Agitation—Epirubicin—uterine cancer	0.00017	0.00114	CcSEcCtD
Amitriptyline—Rash—Etoposide—uterine cancer	0.00017	0.00114	CcSEcCtD
Amitriptyline—Dermatitis—Etoposide—uterine cancer	0.00017	0.00114	CcSEcCtD
Amitriptyline—Headache—Etoposide—uterine cancer	0.000169	0.00114	CcSEcCtD
Amitriptyline—Dysgeusia—Doxorubicin—uterine cancer	0.000168	0.00113	CcSEcCtD
Amitriptyline—Malaise—Epirubicin—uterine cancer	0.000167	0.00112	CcSEcCtD
Amitriptyline—Syncope—Epirubicin—uterine cancer	0.000166	0.00112	CcSEcCtD
Amitriptyline—Leukopenia—Epirubicin—uterine cancer	0.000166	0.00111	CcSEcCtD
Amitriptyline—Palpitations—Epirubicin—uterine cancer	0.000164	0.0011	CcSEcCtD
Amitriptyline—Loss of consciousness—Epirubicin—uterine cancer	0.000163	0.00109	CcSEcCtD
Amitriptyline—Vision blurred—Doxorubicin—uterine cancer	0.000161	0.00109	CcSEcCtD
Amitriptyline—Convulsion—Epirubicin—uterine cancer	0.00016	0.00108	CcSEcCtD
Amitriptyline—Nausea—Etoposide—uterine cancer	0.00016	0.00108	CcSEcCtD
Amitriptyline—Hypertension—Epirubicin—uterine cancer	0.00016	0.00108	CcSEcCtD
Amitriptyline—Ill-defined disorder—Doxorubicin—uterine cancer	0.000159	0.00107	CcSEcCtD
Amitriptyline—Agitation—Doxorubicin—uterine cancer	0.000157	0.00106	CcSEcCtD
Amitriptyline—Anxiety—Epirubicin—uterine cancer	0.000157	0.00106	CcSEcCtD
Amitriptyline—Discomfort—Epirubicin—uterine cancer	0.000156	0.00105	CcSEcCtD
Amitriptyline—Malaise—Doxorubicin—uterine cancer	0.000154	0.00104	CcSEcCtD
Amitriptyline—Dry mouth—Epirubicin—uterine cancer	0.000154	0.00104	CcSEcCtD
Amitriptyline—Syncope—Doxorubicin—uterine cancer	0.000154	0.00103	CcSEcCtD
Amitriptyline—Leukopenia—Doxorubicin—uterine cancer	0.000153	0.00103	CcSEcCtD
Amitriptyline—Confusional state—Epirubicin—uterine cancer	0.000152	0.00102	CcSEcCtD
Amitriptyline—Palpitations—Doxorubicin—uterine cancer	0.000151	0.00102	CcSEcCtD
Amitriptyline—Oedema—Epirubicin—uterine cancer	0.000151	0.00102	CcSEcCtD
Amitriptyline—Loss of consciousness—Doxorubicin—uterine cancer	0.000151	0.00101	CcSEcCtD
Amitriptyline—Shock—Epirubicin—uterine cancer	0.000149	0.001	CcSEcCtD
Amitriptyline—Convulsion—Doxorubicin—uterine cancer	0.000148	0.000998	CcSEcCtD
Amitriptyline—Thrombocytopenia—Epirubicin—uterine cancer	0.000148	0.000995	CcSEcCtD
Amitriptyline—Hypertension—Doxorubicin—uterine cancer	0.000148	0.000995	CcSEcCtD
Amitriptyline—Tachycardia—Epirubicin—uterine cancer	0.000147	0.000992	CcSEcCtD
Amitriptyline—Hyperhidrosis—Epirubicin—uterine cancer	0.000146	0.000983	CcSEcCtD
Amitriptyline—Anxiety—Doxorubicin—uterine cancer	0.000145	0.000978	CcSEcCtD
Amitriptyline—Discomfort—Doxorubicin—uterine cancer	0.000144	0.000969	CcSEcCtD
Amitriptyline—Anorexia—Epirubicin—uterine cancer	0.000144	0.000969	CcSEcCtD
Amitriptyline—Dry mouth—Doxorubicin—uterine cancer	0.000143	0.000959	CcSEcCtD
Amitriptyline—Hypotension—Epirubicin—uterine cancer	0.000141	0.00095	CcSEcCtD
Amitriptyline—Confusional state—Doxorubicin—uterine cancer	0.000141	0.000948	CcSEcCtD
Amitriptyline—Oedema—Doxorubicin—uterine cancer	0.00014	0.00094	CcSEcCtD
Amitriptyline—Shock—Doxorubicin—uterine cancer	0.000138	0.000925	CcSEcCtD
Amitriptyline—Thrombocytopenia—Doxorubicin—uterine cancer	0.000137	0.000921	CcSEcCtD
Amitriptyline—Insomnia—Epirubicin—uterine cancer	0.000137	0.000919	CcSEcCtD
Amitriptyline—Tachycardia—Doxorubicin—uterine cancer	0.000136	0.000918	CcSEcCtD
Amitriptyline—Paraesthesia—Epirubicin—uterine cancer	0.000136	0.000913	CcSEcCtD
Amitriptyline—Hyperhidrosis—Doxorubicin—uterine cancer	0.000135	0.000909	CcSEcCtD
Amitriptyline—Somnolence—Epirubicin—uterine cancer	0.000134	0.000904	CcSEcCtD
Amitriptyline—Anorexia—Doxorubicin—uterine cancer	0.000133	0.000896	CcSEcCtD
Amitriptyline—Dyspepsia—Epirubicin—uterine cancer	0.000133	0.000895	CcSEcCtD
Amitriptyline—Decreased appetite—Epirubicin—uterine cancer	0.000131	0.000884	CcSEcCtD
Amitriptyline—Hypotension—Doxorubicin—uterine cancer	0.000131	0.000879	CcSEcCtD
Amitriptyline—Fatigue—Epirubicin—uterine cancer	0.00013	0.000876	CcSEcCtD
Amitriptyline—Constipation—Epirubicin—uterine cancer	0.000129	0.000869	CcSEcCtD
Amitriptyline—Insomnia—Doxorubicin—uterine cancer	0.000126	0.000851	CcSEcCtD
Amitriptyline—Paraesthesia—Doxorubicin—uterine cancer	0.000126	0.000844	CcSEcCtD
Amitriptyline—Feeling abnormal—Epirubicin—uterine cancer	0.000124	0.000838	CcSEcCtD
Amitriptyline—Somnolence—Doxorubicin—uterine cancer	0.000124	0.000836	CcSEcCtD
Amitriptyline—Dyspepsia—Doxorubicin—uterine cancer	0.000123	0.000828	CcSEcCtD
Amitriptyline—Decreased appetite—Doxorubicin—uterine cancer	0.000121	0.000818	CcSEcCtD
Amitriptyline—Fatigue—Doxorubicin—uterine cancer	0.000121	0.000811	CcSEcCtD
Amitriptyline—Urticaria—Epirubicin—uterine cancer	0.00012	0.000807	CcSEcCtD
Amitriptyline—Constipation—Doxorubicin—uterine cancer	0.00012	0.000804	CcSEcCtD
Amitriptyline—Body temperature increased—Epirubicin—uterine cancer	0.000119	0.000803	CcSEcCtD
Amitriptyline—Feeling abnormal—Doxorubicin—uterine cancer	0.000115	0.000775	CcSEcCtD
Amitriptyline—ABCB1—lymph node—uterine cancer	0.000113	0.00125	CbGeAlD
Amitriptyline—Urticaria—Doxorubicin—uterine cancer	0.000111	0.000747	CcSEcCtD
Amitriptyline—Body temperature increased—Doxorubicin—uterine cancer	0.00011	0.000743	CcSEcCtD
Amitriptyline—Asthenia—Epirubicin—uterine cancer	0.000108	0.000729	CcSEcCtD
Amitriptyline—Pruritus—Epirubicin—uterine cancer	0.000107	0.000719	CcSEcCtD
Amitriptyline—Diarrhoea—Epirubicin—uterine cancer	0.000103	0.000695	CcSEcCtD
Amitriptyline—Asthenia—Doxorubicin—uterine cancer	0.0001	0.000675	CcSEcCtD
Amitriptyline—Dizziness—Epirubicin—uterine cancer	9.99e-05	0.000672	CcSEcCtD
Amitriptyline—Pruritus—Doxorubicin—uterine cancer	9.89e-05	0.000665	CcSEcCtD
Amitriptyline—Vomiting—Epirubicin—uterine cancer	9.6e-05	0.000646	CcSEcCtD
Amitriptyline—Diarrhoea—Doxorubicin—uterine cancer	9.56e-05	0.000643	CcSEcCtD
Amitriptyline—Rash—Epirubicin—uterine cancer	9.52e-05	0.000641	CcSEcCtD
Amitriptyline—Dermatitis—Epirubicin—uterine cancer	9.52e-05	0.00064	CcSEcCtD
Amitriptyline—Headache—Epirubicin—uterine cancer	9.46e-05	0.000637	CcSEcCtD
Amitriptyline—Dizziness—Doxorubicin—uterine cancer	9.24e-05	0.000622	CcSEcCtD
Amitriptyline—Nausea—Epirubicin—uterine cancer	8.97e-05	0.000604	CcSEcCtD
Amitriptyline—Vomiting—Doxorubicin—uterine cancer	8.89e-05	0.000598	CcSEcCtD
Amitriptyline—Rash—Doxorubicin—uterine cancer	8.81e-05	0.000593	CcSEcCtD
Amitriptyline—Dermatitis—Doxorubicin—uterine cancer	8.8e-05	0.000592	CcSEcCtD
Amitriptyline—Headache—Doxorubicin—uterine cancer	8.76e-05	0.000589	CcSEcCtD
Amitriptyline—Nausea—Doxorubicin—uterine cancer	8.3e-05	0.000559	CcSEcCtD
Amitriptyline—HTR1A—Signaling by GPCR—AKT1—uterine cancer	4.66e-06	5.24e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling by GPCR—AKT1—uterine cancer	4.64e-06	5.21e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—HRAS—uterine cancer	4.63e-06	5.21e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—PIK3CA—uterine cancer	4.62e-06	5.19e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.59e-06	5.16e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CXCL8—uterine cancer	4.59e-06	5.16e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CXCL8—uterine cancer	4.58e-06	5.15e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—STK11—uterine cancer	4.57e-06	5.14e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CYP19A1—uterine cancer	4.57e-06	5.14e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CXCL8—uterine cancer	4.56e-06	5.13e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—HRAS—uterine cancer	4.56e-06	5.12e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—EP300—uterine cancer	4.55e-06	5.12e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CDKN1B—uterine cancer	4.55e-06	5.12e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—PIK3CA—uterine cancer	4.55e-06	5.12e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CXCL8—uterine cancer	4.55e-06	5.11e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—HRAS—uterine cancer	4.55e-06	5.11e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—PTEN—uterine cancer	4.55e-06	5.11e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—PIK3CA—uterine cancer	4.55e-06	5.11e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—HRAS—uterine cancer	4.53e-06	5.1e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—EP300—uterine cancer	4.53e-06	5.09e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—HRAS—uterine cancer	4.52e-06	5.08e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—PIK3CA—uterine cancer	4.52e-06	5.08e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CXCL8—uterine cancer	4.51e-06	5.06e-05	CbGpPWpGaD
Amitriptyline—DRD2—GPCR downstream signaling—AKT1—uterine cancer	4.5e-06	5.06e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CXCL8—uterine cancer	4.49e-06	5.05e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—PTEN—uterine cancer	4.49e-06	5.05e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—PIK3CA—uterine cancer	4.48e-06	5.04e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CDKN1B—uterine cancer	4.48e-06	5.04e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—HRAS—uterine cancer	4.48e-06	5.03e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—KRAS—uterine cancer	4.48e-06	5.03e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CDKN1B—uterine cancer	4.47e-06	5.03e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—TP53—uterine cancer	4.47e-06	5.02e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—HRAS—uterine cancer	4.46e-06	5.02e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CDKN1B—uterine cancer	4.46e-06	5.01e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—MTHFR—uterine cancer	4.45e-06	5.01e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CDKN1B—uterine cancer	4.44e-06	4.99e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—AKT1—uterine cancer	4.44e-06	4.99e-05	CbGpPWpGaD
Amitriptyline—HTR2A—GPCR downstream signaling—AKT1—uterine cancer	4.43e-06	4.98e-05	CbGpPWpGaD
Amitriptyline—HRH1—GPCR downstream signaling—AKT1—uterine cancer	4.42e-06	4.97e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—PIK3CA—uterine cancer	4.42e-06	4.97e-05	CbGpPWpGaD
Amitriptyline—CHRM1—GPCR downstream signaling—AKT1—uterine cancer	4.41e-06	4.96e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—TP53—uterine cancer	4.4e-06	4.95e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—ERBB2—uterine cancer	4.4e-06	4.95e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CDKN1B—uterine cancer	4.4e-06	4.95e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—TP53—uterine cancer	4.4e-06	4.94e-05	CbGpPWpGaD
Amitriptyline—CHRM3—GPCR downstream signaling—AKT1—uterine cancer	4.39e-06	4.94e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CDKN1B—uterine cancer	4.39e-06	4.93e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—TP53—uterine cancer	4.37e-06	4.91e-05	CbGpPWpGaD
Amitriptyline—CHRM2—GPCR downstream signaling—AKT1—uterine cancer	4.35e-06	4.89e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—GPCR downstream signaling—AKT1—uterine cancer	4.34e-06	4.88e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—EP300—uterine cancer	4.34e-06	4.88e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—VEGFA—uterine cancer	4.31e-06	4.85e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—AKT1—uterine cancer	4.3e-06	4.84e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CTNNB1—uterine cancer	4.3e-06	4.84e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—PIK3CA—uterine cancer	4.29e-06	4.83e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—VEGFA—uterine cancer	4.29e-06	4.82e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—EP300—uterine cancer	4.28e-06	4.81e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—TP53—uterine cancer	4.28e-06	4.81e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—HRAS—uterine cancer	4.27e-06	4.8e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—NRAS—uterine cancer	4.26e-06	4.79e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—KRAS—uterine cancer	4.25e-06	4.78e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—NRAS—uterine cancer	4.24e-06	4.76e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CTNNB1—uterine cancer	4.23e-06	4.76e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CTNNB1—uterine cancer	4.22e-06	4.75e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—HRAS—uterine cancer	4.21e-06	4.73e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CTNNB1—uterine cancer	4.21e-06	4.73e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PTEN—uterine cancer	4.21e-06	4.73e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—KRAS—uterine cancer	4.21e-06	4.73e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—KRAS—uterine cancer	4.21e-06	4.73e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—HRAS—uterine cancer	4.21e-06	4.73e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CTNNB1—uterine cancer	4.2e-06	4.72e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—PTEN—uterine cancer	4.19e-06	4.71e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—HRAS—uterine cancer	4.18e-06	4.7e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CXCL8—uterine cancer	4.17e-06	4.69e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CTNNB1—uterine cancer	4.16e-06	4.67e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—TP53—uterine cancer	4.15e-06	4.67e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—HRAS—uterine cancer	4.15e-06	4.66e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CTNNB1—uterine cancer	4.14e-06	4.66e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—PTEN—uterine cancer	4.13e-06	4.64e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PTEN—uterine cancer	4.12e-06	4.63e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—PTEN—uterine cancer	4.12e-06	4.63e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PTEN—uterine cancer	4.11e-06	4.62e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—PIK3CA—uterine cancer	4.11e-06	4.62e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—VEGFA—uterine cancer	4.11e-06	4.62e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—PTEN—uterine cancer	4.1e-06	4.61e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—HRAS—uterine cancer	4.09e-06	4.6e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—AKT1—uterine cancer	4.09e-06	4.6e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—PTEN—uterine cancer	4.09e-06	4.6e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CDKN1B—uterine cancer	4.08e-06	4.58e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—NRAS—uterine cancer	4.06e-06	4.56e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—PTEN—uterine cancer	4.05e-06	4.55e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—PTEN—uterine cancer	4.04e-06	4.54e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—GPCR downstream signaling—AKT1—uterine cancer	4.03e-06	4.53e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—AKT1—uterine cancer	4.03e-06	4.52e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—AKT1—uterine cancer	4.02e-06	4.51e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—EP300—uterine cancer	4.01e-06	4.51e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—AKT1—uterine cancer	4e-06	4.5e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—EP300—uterine cancer	4e-06	4.5e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—AKT1—uterine cancer	3.99e-06	4.49e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—TP53—uterine cancer	3.98e-06	4.47e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—HRAS—uterine cancer	3.97e-06	4.47e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—AKT1—uterine cancer	3.95e-06	4.44e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—AKT1—uterine cancer	3.94e-06	4.43e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—EP300—uterine cancer	3.93e-06	4.42e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—EP300—uterine cancer	3.93e-06	4.42e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—EP300—uterine cancer	3.93e-06	4.41e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.93e-06	4.41e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—EP300—uterine cancer	3.92e-06	4.41e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—EP300—uterine cancer	3.91e-06	4.4e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—PIK3CA—uterine cancer	3.9e-06	4.39e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—EP300—uterine cancer	3.9e-06	4.39e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—PIK3CA—uterine cancer	3.87e-06	4.35e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—PIK3CA—uterine cancer	3.87e-06	4.35e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—EP300—uterine cancer	3.86e-06	4.34e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—EP300—uterine cancer	3.85e-06	4.33e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CTNNB1—uterine cancer	3.85e-06	4.33e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—HRAS—uterine cancer	3.8e-06	4.28e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—VEGFA—uterine cancer	3.79e-06	4.26e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—TP53—uterine cancer	3.78e-06	4.24e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—AKT1—uterine cancer	3.77e-06	4.24e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PTEN—uterine cancer	3.75e-06	4.22e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—NRAS—uterine cancer	3.74e-06	4.21e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—TP53—uterine cancer	3.74e-06	4.2e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—TP53—uterine cancer	3.74e-06	4.2e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—VEGFA—uterine cancer	3.73e-06	4.19e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—VEGFA—uterine cancer	3.72e-06	4.18e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—AKT1—uterine cancer	3.72e-06	4.18e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—AKT1—uterine cancer	3.71e-06	4.18e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—VEGFA—uterine cancer	3.71e-06	4.17e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—VEGFA—uterine cancer	3.69e-06	4.15e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—AKT1—uterine cancer	3.69e-06	4.15e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—NRAS—uterine cancer	3.68e-06	4.14e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—NRAS—uterine cancer	3.67e-06	4.13e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—KRAS—uterine cancer	3.67e-06	4.12e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—AKT1—uterine cancer	3.66e-06	4.12e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—NRAS—uterine cancer	3.66e-06	4.12e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—VEGFA—uterine cancer	3.66e-06	4.11e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—NRAS—uterine cancer	3.65e-06	4.1e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—VEGFA—uterine cancer	3.65e-06	4.1e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—KRAS—uterine cancer	3.65e-06	4.1e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—NRAS—uterine cancer	3.61e-06	4.06e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—AKT1—uterine cancer	3.61e-06	4.06e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—HRAS—uterine cancer	3.61e-06	4.06e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—NRAS—uterine cancer	3.6e-06	4.05e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—EP300—uterine cancer	3.58e-06	4.02e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—HRAS—uterine cancer	3.58e-06	4.02e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—HRAS—uterine cancer	3.58e-06	4.02e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PTEN—uterine cancer	3.56e-06	4.01e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PTEN—uterine cancer	3.54e-06	3.98e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—AKT1—uterine cancer	3.51e-06	3.94e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—KRAS—uterine cancer	3.49e-06	3.93e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—PIK3CA—uterine cancer	3.45e-06	3.88e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—MTHFR—uterine cancer	3.44e-06	3.86e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—EP300—uterine cancer	3.4e-06	3.82e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—VEGFA—uterine cancer	3.39e-06	3.81e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—EP300—uterine cancer	3.38e-06	3.8e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—PIK3CA—uterine cancer	3.37e-06	3.79e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—AKT1—uterine cancer	3.36e-06	3.78e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—PIK3CA—uterine cancer	3.35e-06	3.77e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—NRAS—uterine cancer	3.35e-06	3.76e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TP53—uterine cancer	3.26e-06	3.66e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TP53—uterine cancer	3.24e-06	3.64e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—KRAS—uterine cancer	3.22e-06	3.62e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—PIK3CA—uterine cancer	3.21e-06	3.61e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—AKT1—uterine cancer	3.19e-06	3.58e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTEN—uterine cancer	3.18e-06	3.58e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—KRAS—uterine cancer	3.17e-06	3.56e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—PIK3CA—uterine cancer	3.17e-06	3.56e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—KRAS—uterine cancer	3.16e-06	3.55e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—AKT1—uterine cancer	3.16e-06	3.55e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—AKT1—uterine cancer	3.16e-06	3.55e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—KRAS—uterine cancer	3.15e-06	3.54e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—KRAS—uterine cancer	3.14e-06	3.53e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—HRAS—uterine cancer	3.12e-06	3.5e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—KRAS—uterine cancer	3.11e-06	3.5e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTEN—uterine cancer	3.1e-06	3.49e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TP53—uterine cancer	3.1e-06	3.49e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—KRAS—uterine cancer	3.1e-06	3.49e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—HRAS—uterine cancer	3.1e-06	3.49e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—EP300—uterine cancer	3.03e-06	3.41e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PIK3CA—uterine cancer	2.97e-06	3.34e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—HRAS—uterine cancer	2.97e-06	3.34e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—EP300—uterine cancer	2.96e-06	3.33e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—PIK3CA—uterine cancer	2.96e-06	3.33e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTEN—uterine cancer	2.93e-06	3.29e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—PIK3CA—uterine cancer	2.91e-06	3.27e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PIK3CA—uterine cancer	2.91e-06	3.27e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—PIK3CA—uterine cancer	2.9e-06	3.26e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PIK3CA—uterine cancer	2.9e-06	3.26e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTEN—uterine cancer	2.9e-06	3.26e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—PIK3CA—uterine cancer	2.9e-06	3.25e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—PIK3CA—uterine cancer	2.89e-06	3.24e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—KRAS—uterine cancer	2.88e-06	3.24e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TP53—uterine cancer	2.86e-06	3.22e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—PIK3CA—uterine cancer	2.86e-06	3.21e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—PIK3CA—uterine cancer	2.85e-06	3.2e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—AKT1—uterine cancer	2.82e-06	3.17e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TP53—uterine cancer	2.82e-06	3.17e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TP53—uterine cancer	2.81e-06	3.16e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TP53—uterine cancer	2.8e-06	3.15e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TP53—uterine cancer	2.79e-06	3.14e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—EP300—uterine cancer	2.79e-06	3.14e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—EP300—uterine cancer	2.77e-06	3.11e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TP53—uterine cancer	2.76e-06	3.11e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TP53—uterine cancer	2.76e-06	3.1e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—AKT1—uterine cancer	2.75e-06	3.09e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—AKT1—uterine cancer	2.74e-06	3.08e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—HRAS—uterine cancer	2.74e-06	3.08e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—HRAS—uterine cancer	2.69e-06	3.03e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—HRAS—uterine cancer	2.69e-06	3.02e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—HRAS—uterine cancer	2.68e-06	3.01e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—HRAS—uterine cancer	2.67e-06	3e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PIK3CA—uterine cancer	2.65e-06	2.98e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—HRAS—uterine cancer	2.64e-06	2.97e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—HRAS—uterine cancer	2.64e-06	2.96e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—AKT1—uterine cancer	2.62e-06	2.95e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—AKT1—uterine cancer	2.59e-06	2.91e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TP53—uterine cancer	2.56e-06	2.88e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PIK3CA—uterine cancer	2.51e-06	2.83e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PIK3CA—uterine cancer	2.5e-06	2.81e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTEN—uterine cancer	2.48e-06	2.79e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—HRAS—uterine cancer	2.45e-06	2.75e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—AKT1—uterine cancer	2.43e-06	2.73e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—AKT1—uterine cancer	2.42e-06	2.72e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—AKT1—uterine cancer	2.38e-06	2.67e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—AKT1—uterine cancer	2.38e-06	2.67e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—AKT1—uterine cancer	2.37e-06	2.67e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—AKT1—uterine cancer	2.37e-06	2.66e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—AKT1—uterine cancer	2.37e-06	2.66e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—EP300—uterine cancer	2.36e-06	2.66e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—AKT1—uterine cancer	2.36e-06	2.65e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—AKT1—uterine cancer	2.33e-06	2.62e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—AKT1—uterine cancer	2.33e-06	2.62e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.24e-06	2.52e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PIK3CA—uterine cancer	2.19e-06	2.46e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—AKT1—uterine cancer	2.16e-06	2.43e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CA—uterine cancer	2.06e-06	2.32e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—AKT1—uterine cancer	2.05e-06	2.31e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CA—uterine cancer	2.05e-06	2.3e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—AKT1—uterine cancer	2.04e-06	2.3e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTEN—uterine cancer	1.91e-06	2.15e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—AKT1—uterine cancer	1.83e-06	2.06e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—EP300—uterine cancer	1.82e-06	2.05e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—AKT1—uterine cancer	1.79e-06	2.01e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.75e-06	1.97e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—AKT1—uterine cancer	1.69e-06	1.89e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—AKT1—uterine cancer	1.67e-06	1.88e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—AKT1—uterine cancer	1.43e-06	1.61e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.35e-06	1.52e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—AKT1—uterine cancer	1.1e-06	1.24e-05	CbGpPWpGaD
